精品行业研究报告

1.EXECUTIVESUMMARY

·ExecutiveSummary

 Introduction

2.MARKETINTRODUCTION

·Overview

 ScopeandSegmentation

 ResearchMethodology

·DiseaseOverview

 Asthma

 COPD

 TreatmentOptions

·MarketOverview

 MarketEngineeringMeasurements

 IndustryChallengesandStrategicRecommendations

 MarketDrivers

 MarketRestraints

3.TOTALMARKETANALYSIS

·CompetitiveAnalysis

 CompetitiveStructure

·PatientForecasts

 PatientForecasts-Asthma

 PatientForecasts-COPD

 TotalPatientForecasts

·RevenueForecasts

 TotalMarketRevenueForecasts

 MarketShareAnalysis

4.BRONCHODILATORSMARKET

·Introduction

 Introduction

 MarketEngineeringMeasurements

 RevenueForecasts

 MarketShareAnalysis

·Short-ActingBeta-2AgonistsMarket

 Introduction

 RevenueForecasts

 ProductAnalysis

 PipelineAnalysis

·Long-ActingBeta-2AgonistsMarket

 Introduction

 RevenueForecasts

 ProductAnalysis

 PipelineAnalysis

·AnticholinergicsMarket

 Introduction

 RevenueForecasts

 ProductAnalysis

 PipelineAnalysis

·CombinationBronchodilators

 Introduction

 RevenueForecasts

 ProductAnalysis

 PipelineAnalysis

5.ANTI-INFLAMMATORYMARKET

·Introduction

 Introduction

 MarketEngineeringMeasurements

 RevenueForecasts

 MarketShareAnalysis

·InhaledCorticosteroidsMarket

 Introduction

 RevenueForecasts

 ProductAnalysis

 PipelineAnalysis

·Mediator-ReleaseInhibitorMarket

 Introduction

 RevenueForecasts

 ProductAnalysis

 PipelineAnalysis

·Anti-LeukotrieneMarket

 Introduction

 RevenueForecasts

 PipelineAnalysis

·MonoclonalAntibodyMarket

 Introduction

 RevenueForecasts

 PipelineAnalysis

·OtherEmergingAnti-Inflammatories

 PipelineAnalysis

6.COMBINATIONTHERAPIESMARKET

·CombinationTherapies

 Introduction

 MarketEngineeringMeasurements

 RevenueForecasts

 ProductAnalysis

7.APPENDIX

·DecisionSupportDatabases

 MortalityDuetoAsthmaBronchitisandEmphysema

 PrevalenceofAsthma

 PrevalenceofChronicObstructivePulmonaryDisease

 FemalePopulation65andAbove

 MalePopulation65andAbove

　　This research service covers the U.S. asthma/COPD market from 2003-2013. Included are a therapeutic overview, patient forecasts, total market revenue forecasts, market segment revenue forecasts, and market share analysis. The market is segmented by product class: bronchodilators, anti-inflammatories, and combination therapies. Major market challenges, drivers, restraints, and strategic recommendations to overcome market challenges are also discussed.